Artizan Biosciences has inked a lease to occupy 10,000 square feet of Class A laboratory and office space at Winchester Works in New Haven.
The New Haven-based biotechnology company is focused on therapeutics that disrupt triggers of chronic inflammatory disease. Artizan anticipates that its lead product candidate for inflammatory bowel disease will be in the clinic by 2023.